Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
1 No. ECF2 029/2561 28 June 2018 Subject The Entering into an Investment of the construction of the Manufacturing Plant and Distributing of the Medium Density Fiber Board or MDF Board in Narathiwat
facilities apart from the usual depreciation expenses 4.2) Asset Obligations -None- (information as of 27 June 2018) 5. Value of the consideration Paid The transaction of investing in manufacturing plant and
Non-funded working capital facilities by 2.5% p.a. During this period IRSL management focused on all aspects of operational excellence and targeted saving of USD 11 Million by 2021. On market front IRSL
a development project of tourist facilities on Emboodhoo Lagoon in the Republic of Maldives (“Crossroads”), by acquiring interests in a separated head lease, which covers three resorts and an
(Schedule 1) are set out in the Appendix 1. 2. Approved the Company entering into credit facilities agreement with TMB Bank Public Company Limited and Bangkok Bank Public Company Limited, each for an amount
ที่ กบร No. Kor Bor Ror. 032/2017 November 9, 2017 President The Stock Exchange of Thailand Re : Increase of the investment proportion in the ordinary shares of Pattaya Manufacturing Co., Ltd. Dear
regulatory risks in markets where the Company op- erates; dependence on availability, sourcing and cost of raw materials; ability to maintain cost structure and efficient operation of manufacturing facilities
commercial and passenger cars. Export-related manufacturing production, especially automotive, has continued to improve. The consensus view for 4% GDP growth in 2018 maybe revised upwards given the strong end